Gerben Albert Eleutherius Vant Klooster,Herman Augustinus De Kock,Pierre Jean-Marie Bernard Raboisson,Christel Florentina E. Van Den Eynde
申请号：
US12445039
公开号：
US20120220520A1
申请日:
2007.01.26
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). The combination is useful to improve the bioavailability of the HCV NS3/4a protease inhibitor. As such, the combination is useful for treating conditions associated with the Hepatitis C virus in patients. Pharmaceutical compositions and kits comprising this combination, and processes for preparing the combination and the pharmaceutical formulations are also provided.
